COMING SOON - E-CONTROL Rx Anti-estrogen

IronMagLabs

IronMagLabs

Active member
Awards
1
  • Established
COMING SOON - E-CONTROL Rx Anti-estrogen

that is all I can say right now... :)
 
RoadBlocK

RoadBlocK

Well-known member
Awards
1
  • Established
Looking forward to hearing about this. Sub'd for info.
 
ryansm

ryansm

Well-known member
Awards
2
  • RockStar
  • Established
Is this a new compound? Definitely interested if it is.
 
IronMagLabs

IronMagLabs

Active member
Awards
1
  • Established
Is this a new compound? Definitely interested if it is.
not a new compound, just a very good one
(1,4,6-androstatriene-3,17-dione)
that many companies have pulled off the market. ;)
 

stxnas

Well-known member
Awards
2
  • RockStar
  • Established
That's ATD for those of you too lazy to look it up :D
 
heavyiron

heavyiron

Board Sponsor
Awards
1
  • Established
Gotta love it when someone has the balls to bring back a product that was pulled off the market...
 

BrYmAsTeR17

Banned
Awards
1
  • Established
Well you guys really jumped off the wagon, way to be original!

LOLOLOL

At least we know ATD is still alive and kicking.
 
IronMagLabs

IronMagLabs

Active member
Awards
1
  • Established
good news!!! we should have E-Control Rx in stock by Nov.15
 
heavyiron

heavyiron

Board Sponsor
Awards
1
  • Established
1,4,6 Androstatriene-dione (ATD)


Characteristics

ATD is a steroidal aromatase inhibitor, known as a suicidal inhibitor because it permanently binds to the aromatase enzyme.

ATD is used for its aromatase inhibiting and testosterone boosting effect. Its effectiveness at lowering estrogen appears to be stronger than 6-oxo. It converts to 1,4,6-testosterone, which would also be expected to cause falsely high readings for a testosterone analysis.

The 1,4,6-testosterone metabolite of ATD can also bind to the androgen receptor (AR) and induce androgenic (or possibly anti-androgenic) effects similar to what is seen from 6-oxo. This would be expected since 1,4,6-testosterone has about one third the binding affinity for the AR, therefore it may interefere with the anabolic or androgenic action of hormones which bind the androgen receptor.

ATD would also be expected to interfere with production of natural testosterone by acting upon the hypothalamus pituitary testicular axis (HPTA), therefore this compound should not be used during post cycle therapy (PCT), however it could successfully be used during a cycle to help keep estrogen in control. Anecdotal reports and animal studies have also shown ATD inhibits libido and general sexual potency.

References

Effect of an inhibitor of aromatization, 1,4,6 androstatriene-3,17-dione (ATD) on LH release and steroid binding in hypothalamus of adult female rats.

Exp Brain Res. 1986;64(3):407-10.
Slama A, Gogan F, Sarrieau A, Vial M, Rostene W, Kordon C.

Effects of ATD on male sexual behavior and androgen receptor binding: a reexamination of the aromatization hypothesis.

ME Kaplan and MY McGinnis
Horm Behav, Mar 1989; 23(1): 10-26.

Anabolic Pharmacology
Seth Roberts (2009)

By Jason Rowland


Chemical Name(s):

Androsta-1,4,6-triene-3,17-dione
1,4,6-androstatriene-3,17-dione

Chemical Formula: C19H22O2

Molecular Weight: 282

CAS: NA

Q Qatio: NA

Anabolic #: NA

Androgenic #: NA

Oral Bioavailability: Estimated at 4%

AR Binding Affinity: NA

SHBG Binding Affinity: NA

Half Life: 2 days

Legal Status (US): Not listed as a controlled substance

Average Dose: 25-100mg/day

Average Cycle Length: 4-8 weeks
 

Attachments

IronMagLabs

IronMagLabs

Active member
Awards
1
  • Established
E-Control Rx will be in stock on Monday, all orders placed today and this weekend will ship no later than Tuesday.
 

Similar threads


Top